Integrated Diagnostics Holdings plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IDGXF research report →
Companywww.idhcorp.com
Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 2,000 diagnostic test services, including immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. The company operates in Egypt, Jordan, Sudan, and Nigeria.
- CEO
- Hend El Sherbini
- IPO
- 2019
- Employees
- 6,309
- HQ
- Saint Helier, JE
Price Chart
Valuation
- Market Cap
- $345.69M
- P/E
- 21.47
- P/S
- 3.43
- P/B
- 5.67
- EV/EBITDA
- 11.52
- Div Yield
- 2.98%
Profitability
- Gross Margin
- 41.09%
- Op Margin
- 25.24%
- Net Margin
- 16.00%
- ROE
- 27.62%
- ROIC
- 14.93%
Growth & Income
- Revenue
- $7.86B · 37.34%
- Net Income
- $1.26B · 17.15%
- EPS
- $2.17 · 19.23%
- Op Income
- $2.12B
- FCF YoY
- 2.93%
Performance & Tape
- 52W High
- $0.70
- 52W Low
- $0.32
- 50D MA
- $0.63
- 200D MA
- $0.59
- Beta
- 0.35
- Avg Volume
- 15
Get TickerSpark's AI analysis on IDGXF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our IDGXF Coverage
We haven't published any research on IDGXF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate IDGXF Report →